SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001580642-23-006180
Filing Date
2023-11-13
Accepted
2023-11-13 16:10:12
Documents
1
Group Members
FINNY KURUVILLA, M.D. PH. D.ROBIN C. JOHN

Document Format Files

Seq Description Document Type Size
1 SC 13G vynetherapeutics13g.htm SC 13G 57393
  Complete submission text file 0001580642-23-006180.txt   59381
Mailing Address ONE INTERNATIONAL PLACE SUITE 4210 BOSTON MA 02110
Business Address ONE INTERNATIONAL PLACE SUITE 4210 BOSTON MA 02110 877-771-3836
EVENTIDE ASSET MANAGEMENT, LLC (Filed by) CIK: 0001442891 (see all company filings)

IRS No.: 262508416 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 685 ROUTE 202/206 N., SUITE 301 BRIDGEWATER NJ 08807
Business Address 685 ROUTE 202/206 N., SUITE 301 BRIDGEWATER NJ 08807 800-775-7936
VYNE Therapeutics Inc. (Subject) CIK: 0001566044 (see all company filings)

IRS No.: 453757789 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90268 | Film No.: 231398760
SIC: 2834 Pharmaceutical Preparations